Christopher Watt, MD, PhD, Associate Director, and Debbie Nielsen, Manager, of the Molecular Pathology Lab, comment in LabRoots Daily about new codes for three highly-specific screening designations for Human papillomavirus (HPV). This refinement advances patient care—the prior code set lacked a distinct code to note the precise gene linked with HPV for high- and low-risk. They say that the new codes have not altered the workflow in their laboratory.